FMGE oriented details notes on Otitis Media. Integrating it with other subjects

Reading File
Finding Sources
Finding Sources
Searching the Web

FMGE otitis media high yield topics 2024 2025

Reading File
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
I now have very comprehensive material from multiple authoritative textbooks. Let me compile the detailed FMGE-oriented notes.

Otitis Media - FMGE High-Yield Integrated Notes

1. ANATOMY INTEGRATION (Gray's Anatomy / Cummings)

Eustachian (Auditory) Tube - The Key Structure

FeatureChildAdult
Length~18 mm~35 mm
Angle with horizontal~10° (nearly horizontal)~45°
PatencyMore compliant/floppyMore rigid
ImplicationHigher incidence of OM in childrenLess prone to OM
  • The ET opens into the nasopharynx - adenoid hypertrophy blocks the ET orifice → OM
  • Muscles involved in ET opening: Tensor veli palatini (main) and Levator veli palatini - both from the mandibular nerve (V3) and pharyngeal plexus
  • Cleft palate → tensor veli palatini dysfunction → chronic ET dysfunction → OME (FMGE favorite)
  • The ET lining is pseudostratified ciliated columnar epithelium (same as respiratory tract - important in pathogenesis)

2. CLASSIFICATION OF OTITIS MEDIA

OTITIS MEDIA
├── Acute Otitis Media (AOM) — < 6 weeks duration
├── Otitis Media with Effusion (OME) / "Glue Ear" / "Serous OM"
│   — non-purulent fluid, no acute inflammation
└── Chronic Otitis Media (COM)
    ├── Chronic Active OM
    │   ├── WITH Cholesteatoma (unsafe/dangerous type)
    │   └── WITHOUT Cholesteatoma (tubotympanic/safe type)
    └── Chronic Inactive OM
        ├── With perforation
        ├── With retraction pocket
        └── Adhesive OM
(Nadol classification - Shambaugh Surgery of the Ear)

3. MICROBIOLOGY INTEGRATION

AOM (Bacterial Pathogens - Classic Triad)

OrganismNotes
Streptococcus pneumoniaeMost common overall; most likely to cause complications
Haemophilus influenzaeNon-typeable strains; associated with conjunctivitis-otitis syndrome
Moraxella catarrhalisBeta-lactamase producing; high spontaneous resolution rate
  • Mnemonic: "She Has More" (S. pneumo > H. flu > M. catarrhalis)
  • Viral precursors: RSV, Rhinovirus, Coronavirus, Influenza A, Adenovirus, Parainfluenza
  • Fungal OM: Aspergillus, Candida - think immunocompromised patients

COM (CSOM) Organisms

TypeOrganism
Mucosal/TubotympanicStreptococcus, Haemophilus, Pseudomonas, anaerobes
CholesteatomaPseudomonas aeruginosa (most common), Proteus, S. aureus
Malignant OEPseudomonas aeruginosa (also Aspergillus in immunocompromised)

4. PATHOPHYSIOLOGY INTEGRATION

Stages of AOM (Pathology correlation)

  1. Hyperemia stage - mucosal congestion, ET blockade
  2. Exudation stage - serous exudate → PMNs infiltrate → middle-ear pressure rises
  3. Suppuration stage - pus forms; TM bulges
  4. Resolution - pus resorbs OR TM perforates → discharge (pressure relief)
  5. If effusion persists after resolution → OME

Histology of AOM (Shambaugh)

  • Hematoxylin & eosin: acute inflammatory exudate with PMNs + eosinophilic secretions in middle ear space
  • Mucosal lining and TM are thickened
  • Process extends into mastoid air cells (all AOM has some degree of radiological mastoiditis)

OME Pathophysiology

  • ET dysfunction → inadequate gas exchange → negative middle-ear pressure → transudate formation
  • Pepsin/pepsinogen detected in middle-ear effusions → possible role of GERD (Scott-Brown's)
  • Low pH reduces ciliary motility → worsens ET drainage
  • GERD prevalence in OME: 17.6-64% (clinical pearl for FMGE)

5. CLINICAL FEATURES

AOM

  • Otalgia (ear pain) - most prominent symptom
  • Fever
  • Conductive hearing loss
  • Purulent otorrhea if TM ruptures
  • Otoscopy: TM erythematous + bulging (the two cardinal signs)
  • Tympanometry: flat (Type B) tympanogram + absent acoustic reflexes
  • Audiometry: conductive hearing loss

Bullous Myringitis

  • Bullae on TM - associated with AOM
  • Previously attributed to Mycoplasma pneumoniae (OUTDATED) - now known to be typical AOM organisms
  • Treatment same as AOM (FMGE frequently tests this)

OME ("Glue Ear")

  • Painless hearing loss in a child (often incidental)
  • TM: retracted, amber-colored, air-bubble visible behind it
  • Type B tympanogram (flat) but without features of acute infection
  • Most common cause of acquired conductive hearing loss in children

COM - SAFE TYPE (Tubotympanic/Mucosal)

  • Central perforation of TM (pars tensa)
  • Mucoid/mucopurulent discharge
  • Conductive hearing loss
  • No cholesteatoma, no bone erosion
  • Treatment: conservative (Dry mopping + topical antibiotics), surgery if persistent

COM - UNSAFE TYPE (Atticoantral/Cholesteatoma)

  • Attic perforation (pars flaccida / Shrapnell's membrane) OR posterior marginal perforation
  • Foul-smelling scanty discharge (keratin debris)
  • Conductive hearing loss (mixed if labyrinthine fistula)
  • Aural polyp - highly suggestive of cholesteatoma
  • FMGE key: Chronically draining ear not responding to antibiotics → think cholesteatoma

6. CHOLESTEATOMA (Integrated Pathology)

Definition

  • "Benign tumor" of stratified squamous epithelium in middle ear/mastoid
  • Produces and accumulates desquamated keratin debris
  • Annual incidence: 3/100,000 children, 9.2/100,000 adults (slight male predominance)

Types

TypeFeature
CongenitalBehind intact TM, no history of OM or ear surgery; remnant of ectodermal cells
Acquired (primary)Retraction pocket of pars flaccida; related to ET dysfunction
Acquired (secondary)Migration of squamous epithelium through perforation or surgery

Theories of Pathogenesis (FMGE)

  1. Immigration theory - squamous epithelium migrates through perforation
  2. Invagination/retraction pocket theory (most accepted) - retraction of pars flaccida into middle ear
  3. Metaplasia theory - mucosal metaplasia after chronic infection
  4. Implantation theory - traumatic or surgical implantation

Bone Erosion Mechanism

  • Initially affects ossicular chain and scutum
  • Expands to: otic capsule, fallopian canal, tegmen
  • Mechanism: inflammatory mediators (macrophages, monocytes), osteoclasts responsible for resorption
  • Mast cells increased in granulation tissue along eroded surfaces

Imaging

  • CT temporal bone = investigation of choice (shows bony erosion, soft tissue)
  • MRI - NOT useful for bone detail; used for intracranial complications assessment

7. COMPLICATIONS (Integrated Anatomy + Surgery)

Intratemporal Complications

ComplicationNotes
Acute MastoiditisMost common suppurative complication of AOM
LabyrinthitisVia bone erosion or through the round/oval window
Facial Nerve PalsyVia Fallopian canal dehiscence; AOM = antibiotics + myringotomy; CSOM = surgical decompression
Petrositis (Gradenigo's syndrome)Otitis media + ipsilateral VI nerve palsy + retro-orbital pain (triad)
TympanosclerosisCalcium deposits in TM/middle ear

Intracranial Complications

ComplicationNotes
MeningitisMost common intracranial complication
Brain abscessTemporal lobe (from middle ear) > Cerebellum (from mastoid)
Lateral sinus thrombosisSigmoid sinus most commonly involved
Extradural abscess
Subdural abscess
Otitic hydrocephalusRaised ICP without localizing signs

Facial Nerve Palsy in OM (Neurology Integration)

  • AOM: direct extension through Fallopian canal dehiscences, bacterial toxins causing demyelination, ischemia of vasa nervorum
  • CSOM: compression by cholesteatoma (most likely) or inflammation
  • "Facial paralysis + CSOM = suspect cholesteatoma until proven otherwise" - immediate surgical decompression

Mastoiditis - Key Clinical Distinction (FMGE favorite)

FeatureAOMAcute Mastoiditis
Auricular displacementAbsentPresent (pinna pushed forward + downward)
Post-auricular swellingMay haveDefinitive (abscess)
CT findingOpacification (normal)Coalescence + subperiosteal abscess

8. PHARMACOLOGY INTEGRATION (Goodman & Gilman / Tintinalli / Harriet Lane)

Treatment Algorithm - AOM

Initial Decision - Observation vs. Antibiotics:
  • Immediate antibiotics for:
    • All infants < 6 months
    • Severe symptoms (pain ≥48 h, fever >39°C)
    • Bilateral AOM in children < 24 months
    • Recurrent AOM (episode within 2-4 weeks)
    • AOM with perforation
    • Immunocompromised patients
    • Craniofacial abnormalities
  • Watchful waiting (2-3 days) acceptable for:
    • Children ≥24 months with unilateral AOM, mild symptoms, fever <39°C
    • NOT validated in adults

Antibiotic Regimens (Tintinalli)

SituationDrugDose
First-line (uncomplicated)Amoxicillin40-45 mg/kg/day PO BD × 5-10 days
High-dose (resistant S. pneumo)Amoxicillin80-90 mg/kg/day BD (Harriet Lane)
Penicillin allergyCefdinir / Cefuroxime / CefpodoximeStandard doses
Severe PCN allergyClindamycin10 mg/kg/dose TDS
Recent amoxicillin use / concurrent conjunctivitis / recurrent AOMAmoxicillin-clavulanate45 mg/kg/day amoxicillin component BD
Unable to take oral / severeCeftriaxone50 mg/kg IM/IV OD × 1-3 days
With myringotomy tubesOfloxacin otic drops5 drops BD × 5-10 days
KEY FMGE POINT: Fluoroquinolone ear drops (ofloxacin/ciprofloxacin) are safe with non-intact TM; aminoglycoside drops are ototoxic with TM perforation - contraindicated

Antibiotic Failure Management

  • After failure of first-line amoxicillin → Amoxicillin-clavulanate (covers beta-lactamase producers: H. flu, M. catarrhalis)
  • After failure of 2nd line → Ceftriaxone IM × 3 days or ENT referral for myringotomy

CSOM Topical Treatment

  • Safe type (tubotympanic): Topical antibiotics (ciprofloxacin drops) + Dry mopping + Aural toilet
  • Aminoglycosides (neomycin, gentamicin): ototoxic - avoid if TM perforation
  • Systemic antibiotics: Only for exacerbations

Malignant Otitis Externa

  • Organism: Pseudomonas aeruginosa (Aspergillus in immunocompromised)
  • Patient: Elderly + poorly controlled diabetic (immunocompromised)
  • Treatment: Ciprofloxacin 750 mg PO BD × minimum 6-8 weeks
  • Facial palsy = advancing infection → poor prognosis
  • CT: bony erosion of skull base

9. PEDIATRICS INTEGRATION (Harriet Lane)

Age-Related Risk Factors for AOM

  • Peak incidence: 6 months - 2 years
  • Day-care attendance, bottle feeding, passive smoking, cleft palate
  • Breast feeding is protective

Recurrent AOM Definition

  • ≥3 episodes in 6 months OR ≥4 episodes in 12 months

OME and Language Delay

  • OME → persistent conductive hearing loss → speech and language delay
  • The OM-6 questionnaire assesses: physical suffering, hearing loss, speech impairment, emotional distress, activity limitation, caregiver concerns

Grommets (Tympanostomy Tubes) - Indications

  • Recurrent AOM (≥3 in 6 months or ≥4 in 12 months)
  • OME with hearing loss >25 dB lasting ≥3 months
  • At-risk child (cleft palate, Down syndrome)
  • Post-grommet: treat otorrhea with ototopical fluoroquinolone (ofloxacin) drops - NOT systemic antibiotics as first line

10. ENT SURGERY INTEGRATION

Myringotomy

  • Incision in the anteroinferior quadrant of TM (safest area - away from ossicles, chorda tympani, facial nerve)
  • Done under local (adults) or general (children) anesthesia
  • Indications: AOM not responding to antibiotics, severe pain, facial palsy, intracranial complication

Tympanoplasty

  • Repair of TM perforation
  • Success rate: >90% (Harrison's)
  • Types (Wullstein classification):
    • Type I (Myringoplasty): TM repair only, ossicles intact
    • Type II: TM + ossicular repair with malleus erosion
    • Type III: Myringostapedopexy (malleus + incus absent, stapes intact)
    • Type IV: Stapes footplate only mobile
    • Type V: Stapes footplate fixed, semicircular canal fenestration

Mastoidectomy

  • Cortical (simple) mastoidectomy: removes air cells, preserves posterior canal wall - for AOM complications
  • Modified radical mastoidectomy: removes posterior canal wall - for cholesteatoma
  • Radical mastoidectomy (Bondy): removes middle ear contents + posterior wall

11. HEARING LOSS INTEGRATION (Cummings / Harrison's)

ConditionType of Hearing Loss
AOMConductive
OMEConductive (most common cause in children)
COM (mucosal)Conductive
COM + cholesteatoma (labyrinthine erosion)Mixed
CSOM (long-standing, chronic)Mixed (controversial sensorineural component)
Malignant OEConductive → Mixed (if inner ear involved)
  • SNHL is rarely associated with AOM directly (Cummings)
  • Long-standing COM: mixed hearing loss - whether SNHL is due to infection itself or ototoxic drugs/surgery is debated

Tympanometry Types

TypeFindingInterpretation
ANormal peak around 0 daPaNormal middle ear
AsShallow peak (reduced compliance)Otosclerosis, tympanosclerosis
AdDeep/broad peak (increased compliance)Ossicular discontinuity, flaccid TM
BFlat (no peak)OME, AOM, TM perforation
CPeak shifted negative (< -150 daPa)ET dysfunction (early OME)

12. CROSS-SUBJECT HIGH-YIELD INTEGRATION TABLE

TopicSubjectKey Fact
ET anatomyAnatomyChild: horizontal, 18mm; adult: 45°, 35mm
Cleft palate → OMESurgery / AnatomyTensor veli palatini dysfunction
S. pneumoniaeMicrobiologyGram +ve diplococci; most common AOM organism
H. influenzaeMicrobiologyNon-typeable; conjunctivitis-otitis syndrome
M. catarrhalisMicrobiologyBeta-lactamase producer; high spontaneous resolution
PseudomonasMicrobiologyCSOM, cholesteatoma, malignant OE
Amoxicillin mechanismPharmacologyBeta-lactam; inhibits cell wall synthesis (PBP)
Fluoroquinolone (ofloxacin)PharmacologySafe topical even with TM perforation
AminoglycosidesPharmacologyOtotoxic - CONTRAINDICATED with TM perforation
Gradenigo's syndromeNeurology / ENTCN VI palsy + retroorbital pain + otitis media
Lateral sinus thrombosisSurgeryComplication of OM; sigmoid sinus
Bell's palsy vs AOM palsyNeurologyAOM palsy: antibiotics + myringotomy; CSOM: surgery
GERD → OMEGastroenterologyPepsin in middle ear effusion; acid reduces ciliary motility
Down syndromeGeneticsHigher risk OME due to ET anatomy + adenoid hypertrophy
OtosclerosisENTConductive HL, Type As tympanogram; AD inheritance, female, pregnancy-related worsening
Impedance audiometryPhysiologyType B = OM; Type C = ET dysfunction
CT temporal boneRadiologyBest for cholesteatoma; MRI for intracranial complications
Myringotomy siteAnatomy / SurgeryAnteroinferior quadrant of TM

13. FMGE FAVORITE BUZZWORDS & ONE-LINERS

  1. Safest quadrant for myringotomy = Anteroinferior
  2. Most common complication of AOM = Mastoiditis
  3. Most common intracranial complication of OM = Meningitis
  4. Cholesteatoma imaging = CT temporal bone
  5. Cholesteatoma - unsafe ear = Attic/atticoantral/pars flaccida perforation
  6. Safe ear = Tubotympanic/central/pars tensa perforation
  7. Glue ear (OME) = most common cause of acquired conductive HL in children
  8. Foul-smelling scanty discharge + aural polyp = Cholesteatoma until proven otherwise
  9. Pearly white mass behind intact TM in child = Congenital cholesteatoma
  10. Fluoroquinolone drops = Safe with TM perforation; aminoglycosides = NOT safe
  11. Gradenigo's syndrome = Otitis media + CN VI palsy + retroorbital pain (petrous apex)
  12. Malignant OE = Elderly diabetic + Pseudomonas + skull base osteomyelitis + CN VII palsy
  13. GERD + OM = Pepsin/pepsinogen found in middle ear effusion
  14. Cleft palate = Tensor veli palatini dysfunction → chronic OME
  15. Ramsay Hunt syndrome = VZV + facial palsy + ear vesicles (NOT OM, but tested alongside)
  16. After grommet insertion = Treat otorrhea with ototopical fluoroquinolone drops
  17. Bullous myringitis = Treat same as AOM; NOT specifically Mycoplasma (outdated)
  18. Highest spontaneous resolution = M. catarrhalis
  19. Most serious organism in AOM = S. pneumoniae (most complications)
  20. Combined conjunctivitis + otitis = H. influenzae; treat with amoxicillin-clavulanate

14. QUICK RECALL MNEMONICS

AOM organisms: "SHaM"
  • S = Streptococcus pneumoniae (most common)
  • H = Haemophilus influenzae
  • M = Moraxella catarrhalis
COM complications - "MaFaLaP"
  • Mastoiditis
  • Facial palsy
  • Labyrinthitis
  • Petrositis (Gradenigo's)
Intracranial complications - "MaLES-O"
  • Meningitis (most common)
  • Lateral sinus thrombosis
  • Extradural abscess
  • Subdural abscess
  • Otitic hydrocephalus
Wullstein Tympanoplasty Types: "TM, Mal, Inc, Stap, Foot"
  • I: TM repair only
  • II: Malleus involved
  • III: Incus involved (myringostapedopexy)
  • IV: Stapes footplate only
  • V: Footplate fixed, fenestration

Sources:
  • Shambaugh Surgery of the Ear (classification, cholesteatoma, OME)
  • Cummings Otolaryngology Head & Neck Surgery (AOM stages, hearing loss)
  • Tintinalli's Emergency Medicine (treatment algorithms, antibiotic tables)
  • Harrison's Principles of Internal Medicine 22E (conductive HL, ET dysfunction)
  • Scott-Brown's Otorhinolaryngology Vol 1 & 2 (GERD-OM link, facial palsy, complications)
  • Harriet Lane Handbook 23e (pediatric dosing, high-dose amoxicillin)
  • Goodman & Gilman's Pharmacological Basis (amoxicillin, ampicillin indications)
  • Gray's Anatomy for Students (ET anatomy)
This is a shared conversation. Sign in to Orris to start your own chat.